
About this episode
In the September 10, 2024, issue of JACC, Dr. Valentin Fuster highlights groundbreaking research on lipid exposure in early adulthood and its link to later cardiovascular events, the importance of early and serial assessments in cardiogenic shock, and the impact of triglyceride levels on cardiovascular outcomes with alirocumab. He also discusses the association between postnatal opioid exposure and neurodevelopmental outcomes in infants undergoing cardiac surgery, alongside a brief update on the long-term benefits of Mercantor in obstructive hypertrophic cardiomyopathy.
Get every episode summarized
Each time JACC This Week publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from JACC This Week

March 10, 2026: Inside JACC Stats: The State of CV Health in Focus | JACC this W...
JACC This Week

March 3, 2026: Hypertrophic Cardiomyopathy in Focus—MAPLE-HCM Trial, Myosin Inh...
JACC This Week

February 24, 2026: ACHD Guideline in Focus—From Survival to Stewardship | JACC T...
JACC This Week

February 17, 2026: Women's Cardiovascular Health in Focus: From Inclusion to Red...
JACC This Week